Exo-1, Vesicular trafficking inhibitor (ab120292)
Key features and details
- Vesicular trafficking inhibitor
- CAS Number: 461681-88-9
- Purity: > 99%
- Soluble in DMSO to 100 mM and in ethanol to 25 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Exo-1, Vesicular trafficking inhibitor -
Description
Vesicular trafficking inhibitor -
Biological description
Cell-permeable, reversible inhibitor of vesicular trafficking between endoplasmic reticulum and the Golgi apparatus. Inhibits exocytosis with an IC50 of approx. 20 μM. Rapidly releases Arf1 from Golgi membranes. Has similar mechanism of action to brefeldin A (ab120299).
-
Purity
> 99% -
CAS Number
461681-88-9 -
Chemical structure
Properties
-
Chemical name
Methyl 2-(4-fluorobenzamido)benzoate -
Molecular weight
273.26 -
Molecular formula
C15H12FNO3 -
PubChem identifier
310557 -
Storage instructions
Store at Room Temperature. The product can be stored for up to 12 months. -
Solubility overview
Soluble in DMSO to 100 mM and in ethanol to 25 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
O=C(Nc1ccccc1C(=O)OC)c2ccc(F)cc2 -
Source
Synthetic
-
Research areas
Images
-
Chemical Structure - Exo-1, Vesicular trafficking inhibitor (ab120292)2D chemical structure image of ab120292, Exo-1, Vesicular trafficking inhibitor
-
Functional Studies - Exo-1, Vesicular trafficking inhibitor (ab120292)ab86071 staining GBF1 in HeLa cells treated with Exo-1 (ab120292), by ICC/IF. Increase in GBF1 expression correlates with increased concentration of Exo-1 as described in literature.
The cells were incubated at 37°C for 5 minutes in media containing different concentrations of ab120292 ( Exo-1) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab86071 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (2)
ab120292 has been referenced in 2 publications.
- Tran AP et al. Modulation of Receptor Protein Tyrosine Phosphatase Sigma Increases Chondroitin Sulfate Proteoglycan Degradation through Cathepsin B Secretion to Enhance Axon Outgrowth. J Neurosci 38:5399-5414 (2018). PubMed: 29760175
- Luo F et al. Modulation of proteoglycan receptor PTPs enhances MMP-2 activity to promote recovery from multiple sclerosis. Nat Commun 9:4126 (2018). PubMed: 30297691